Clinical Trial

Cell-Free DNA in Hereditary and High-Risk Malignancies

Study Description

Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. The study will also use questionnaires and interviews to understand how patients feel about incorporating these tests into routine medical care, and the perceptions of the medical value of test results.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Genetic - Next generation sequencing (NGS)

NGS

Additional Information

Official Study Title

Early Detection of Cancer in High-risk Patients Through Cell-free DNA

Clinical Trial ID

NCT04261972

ParticipAid ID

epYNra